U.S. Entertainment Stock News

New York Attorney General files a lawsuit alleging widespread consumer fraud on the Zelle payments network, naming Capital One Financial (NYSE:COF) as a co-owner and key shareholder. The case centers on claims that Zelle prioritized growth over security, leading to systemic losses for customers using participating banks. Separately, Capital One reaches a C$35 million settlement in Canada tied to a previous data breach, addressing part of its outstanding legal exposure. Capital One...

First Financial Bancorp. recently reported second-quarter 2026 results showing higher net interest income of US$190.38 million and net income of US$76.46 million compared with a year earlier, while also declaring a quarterly dividend of US$0.26 per share payable on September 15, 2026. The bank is pairing this earnings momentum with expansion, announcing an acquisition of Finward Bancorp that is expected to increase earnings per share and deepen its presence in Northwest Indiana and the...

IDEX (IEX) is back in focus as investors look ahead to its June 2026 earnings report, with expectations for higher earnings and revenue, although recently reduced profit forecasts are tempering confidence. See our latest analysis for IDEX. The IDEX share price has eased in the very short term, with a 1-day share price return that declined 0.42% and a 7-day share price return down 2.94%, but the picture is more constructive over longer periods, including a 90-day share price return of 8.54%, a...

Applied Industrial Technologies has delivered a very large 304.9% total return over the past five years, yet current checks suggest the stock may now be trading at a premium, with both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to overvaluation. Over the last five years, a 304.9% return puts Applied Industrial Technologies among the stronger long term performers, which naturally raises the question of how much of that success is already embedded in...

Protagonist Therapeutics has delivered a very large 3 year return, yet its current valuation screens as expensive on market multiples and only mixed on broader checks, which raises questions about how much optimism is already in the share price. Over the past 3 years, Protagonist Therapeutics has returned roughly 7x, which puts extra focus on whether recent gains can be supported by fundamentals over time. Recent enthusiasm around the company, including a higher price target from Barclays,...

With oil prices above US$100 per barrel, rising geopolitical risks in the Middle East and renewed pressure on growth sectors after higher AI spending plans, many investors are taking a closer look at larger U.S. utilities stocks for potential ballast in a more volatile market. This article walks through how those macro shocks connect to the Utilities Stocks screener and what that might mean for risk, income and capital allocation. It will also reveal 3 stocks from the screener that appear...

The Hartford Insurance Group reported past second-quarter 2026 results with revenue of US$7.26 billion and net income of US$1.30 billion, while authorizing a new share repurchase program of up to US$4.20 billion through 2028 and affirming both common and preferred dividends. Alongside these earnings and capital return moves, The Hartford strengthened its governance and risk oversight by adding former AssuredPartners CEO Randy Larsen to its board and receiving an AM Best affirmation of its A+...

Tronox Holdings (TROX) has drawn fresh attention after its recent share move, with the stock closing at $6.38. Investors are weighing this price against the company’s fundamentals and recent return profile. See our latest analysis for Tronox Holdings. Tronox Holdings’ recent pullback to a 1 day share price return of down 3.63% comes after a strong year to date share price return of 49.41%. The 1 year total shareholder return of 18.60% contrasts with a weaker 3 and 5 year total shareholder...

Sunoco LP previously closed a US$275 million shelf registration, covering 10,000,000 common units in an ESOP-related offering dating back to December 2018. More recently, the market’s attention has shifted to analyst expectations for very large year-over-year earnings and revenue increases in Sunoco’s upcoming August 2026 results. Next, we’ll examine how anticipation of stronger earnings shapes Sunoco’s existing investment narrative around acquisitions, cash flow, and long-term fuel...

Kosmos Energy stock has delivered a very large 206.9% return year to date, and the key question now is whether that move is justified by what the valuation checks are saying about the shares. The 206.9% year to date gain signals that expectations around Kosmos Energy have reset quickly, so recent buyers are effectively paying up for a much stronger outlook than earlier in the year. The recent jump in oil prices after fresh geopolitical tension and new U.S. military action can support higher...

Upcoming earnings put Diamondback Energy in focus Diamondback Energy (FANG) is back on traders' radar after the stock gained 1.22% even as the broader market weakened, with attention centering on its August 3 earnings release and any changes to profit expectations. See our latest analysis for Diamondback Energy. Beyond the latest 1 day move, Diamondback Energy has built up a 7 day share price return of 8.1% and a year to date share price return of 34.9%. Its 1 year total shareholder return of...

Corcept Therapeutics announced in July that it would report its second-quarter 2026 results and host a corporate update call, while analysts recently lifted their full-year earnings estimates and assigned the company a Zacks Rank of #2. What stands out is how Corcept’s sharply improved earnings outlook and analyst sentiment contrast with weaker returns across the broader Medical and Medical – Drugs groups. With this strengthened earnings outlook in focus, we’ll now examine how the latest...

Earlier this week, Adaptive Biotechnologies was upgraded by analysts following upward revisions to earnings estimates, including an expected quarterly loss of US$0.13 per share and forecast revenue of US$66.27 million for the June 2026 quarter. The company’s decision to raise its 2026 MRD revenue guidance to a range of US$260 million to US$270 million highlights how MRD has become the central engine of its business outlook. We’ll now explore how the upgraded earnings expectations and higher...

McCormick stock has retreated sharply over the past few years, yet on most valuation checks it now screens as attractively priced rather than clearly expensive or cheap relative to its fundamentals. Shareholders have seen the stock fall about 39.4% over the past 3 years, which puts recent price action under scrutiny for anyone reassessing McCormick's long term appeal. The planned combination with Unilever's Foods business and a future secondary London listing can reshape how investors think...

Vita Coco Company stock has delivered a strong 161.5% return over the past three years, yet its valuation signals are split, with a Discounted Cash Flow (DCF) view pointing to upside while earnings based multiples suggest the shares are priced rich. Over three years, Vita Coco Company has returned 161.5%, which puts more weight on whether today’s price still leaves room above intrinsic value. Recent acquisitions and expectations for higher earnings can support the DCF based intrinsic value...

MetLife (MET) is back in focus after two separate developments: an expanded bereavement support partnership in Ireland and the completion of a mixed use real estate project in Tampa, which have prompted fresh interest in the stock. See our latest analysis for MetLife. Against this backdrop, MetLife’s share price has moved to $92.54, with a 30 day share price return of 5.12% and a 90 day share price return of 19.10%, while the 1 year total shareholder return of 22.53% and 5 year total...

Trade Desk stock has endured a steep reset, with the share price down about 80.3% over the past three years, yet the broader valuation checks still lean toward the shares looking cheap rather than fully priced in. The roughly 80.3% share price decline over three years signals that sentiment around Trade Desk has shifted sharply, even as the business continues to invest in its advertising platform. Recent moves to deepen retail media data in Japan and add experienced leaders in areas like...

Cinemark Holdings recently attracted attention as analysts projected a year-over-year earnings increase on higher revenues for its latest reported quarter, with Zacks highlighting an Earnings ESP of 6.40% and a Rank #3 status. This gap between the Most Accurate Estimate and the broader consensus suggests analysts see a meaningful chance of Cinemark outperforming expectations, sharpening focus on how its operations are tracking. Now we’ll explore how the prospect of an earnings beat and...

Rexford Industrial Realty, Inc. reported past second quarter 2026 results showing sales of US$243 million, revenue of US$245.51 million, and a net loss of US$504.15 million driven by non-cash impairments, alongside funds from operations of US$0.63 per share that exceeded consensus estimates. Alongside these mixed operating metrics, the company unveiled a new US$1.0 billion stock repurchase program and raised its 2026 disposition guidance to US$1.5–2.0 billion as it repositions its portfolio...

Dividend declaration puts Brunswick in focus Brunswick (BC) has come onto income investors’ radar after the board affirmed a quarterly dividend of $0.44 per share, tied to key August ex dividend and record dates and a September payment. See our latest analysis for Brunswick. The dividend news lands as Brunswick trades at $79.56, with the share price down over the past week and month but slightly higher over 90 days and year to date. Over a longer horizon, the 1 year total shareholder return...

Geopolitical tension, oil above $100 a barrel, higher Treasury yields and fresh tariffs are shaking up expectations across sectors, including US defense and aerospace stocks. Instead of treating this as background noise, it can be useful to look at which companies are most exposed to these headlines and how that risk profile fits your portfolio. This article walks through 3 stocks from our US Defense and Aerospace Stocks screener that appear positively exposed to the current news flow,...

MongoDB (MDB) edged lower by 1.91% in the latest session, underperforming broader market losses as investors weighed expectations for the next quarterly report and the stock’s current valuation. See our latest analysis for MongoDB. At a share price of $299.14, MongoDB has fallen 8.97% over the past week and is down 25.15% on a year to date share price basis, although its 27.21% 1 year total shareholder return points to earlier strength that has recently faded as investors reassess growth...

Dow (DOW) has completed a multi year share buyback, repurchasing 38,539,462 shares for US$2,069.24 million, equal to 5.43% of its stock, following the release of its second quarter 2026 earnings. See our latest analysis for Dow. Dow's latest buyback and stronger second quarter earnings come after a mixed share price patch, with the stock posting a 7 day share price return of 5.46% but a 90 day share price return that declined 20.07%, while the 1 year total shareholder return of 29.70%...

Revolve Group stock is coming off a mixed five year stretch where the share price is down about 64.9%, yet recent gains and stronger international momentum sit against valuation checks that currently point to the shares trading at a premium to intrinsic value. Over the past five years, Revolve Group has delivered a share price decline of about 64.9%, which raises the question of whether the recent recovery has already been fully reflected in the price. International expansion and new...